3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT) : an international, randomised, phase 3, non-inferiority trial
- Submitting institution
-
University of Southampton
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 66896038
- Type
- D - Journal article
- DOI
-
10.1016/S1470-2045(18)30093-7
- Title of journal
- The Lancet Oncology
- Article number
- -
- First page
- 562
- Volume
- 19
- Issue
- 4
- ISSN
- 1470-2045
- Open access status
- Compliant
- Month of publication
- March
- Year of publication
- 2018
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
35
- Research group(s)
-
A - Cancer Sciences
- Citation count
- 67
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- a. The author made a substantial contribution to the organisation of the conduct of the study; and to carrying out the study; and to analysis and interpretation of study data
and
b. The author helped draft the output;
- Non-English
- No
- English abstract
- -
